Trexam 250 mg/5 ml (IM/IV Injection)

5 ml ampoule: ৳ 40.00 (1 x 5: ৳ 200.00)

Medicine Details

Title

  • Trexam 500mg Tablets
  • Tranexamic Acid Hemostatic Medication

Categories

  • Medicine
  • Healthcare
  • Pharmacology
  • Hemostasis
  • Antifibrinolytic
  • Antihemorrhagic
  • Surgery
  • Urology
  • Obstetrics
  • Oncology
  • Stomatology
  • Pharmacological Preparations

Description

  • Used for prophylaxis and therapy of various hemorrhagic conditions
  • Shows antifibrinolytic action
  • 10 times more active than conventional hemostatics
  • Effective in hemoptysis, digestive hemorrhages, leukaemia, cirrhosis, hemophilia, thrombocytopenic purpura, post-operative and traumatic shock, etc.
  • Well absorbed by oral route with effect seen in 15-30 minutes
  • Excreted mainly by renal route
  • Low acute and chronic toxicity
  • No interference with clotting processes
  • Incompatible with penicillins, thrombolytic drugs, and estrogen-containing medications
  • Contraindicated in thromboembolic disease, serious kidney failure, and individual hypersensitivity
  • Side effects may include fatigue, conjunctival irritation, nasal blockage, itching, skin reddening, exanthems, nausea, diarrhea, gastric pyrosis, and rare cases of postural hypotension
  • Should not be administered during known and presumed pregnancy
  • Passes into breast milk in low concentration
  • Prophylactic treatment should begin 24 hours before the operation and continue until 3-4 days after it
  • Therapy of hemorrhages must be prolonged for at least 24 hours after manifestations have disappeared
  • Particular care required in cardiopathic and hepatopathic subjects
  • Belongs to therapeutic class of anti-fibrinolytic and haemostatic drugs
  • Storage at 15-30°C in a dry place away from light and children's reach

Dimensions

  • Tablets: 500mg

Color Options

  • Not Applicable

Functions

  • Prophylaxis and therapy of hemorrhagic conditions
  • Antifibrinolytic action
  • Inhibition of plasminogen activation
  • No interference with clotting processes

Materials

  • Tranexamic Acid (trans-4 aminomethyl-cyclohexanecarboxylic acid)

Technical Specifications

  • 10 times more active than conventional hemostatics
  • Low acute and chronic toxicity
  • Well absorbed by oral route with effect seen in 15-30 minutes
  • Excreted mainly by renal route
  • No interference with clotting processes

Design Elements

  • Synthetic Amino Acid
  • Intravenous and intramuscular administration
  • Oral administration
  • Slow intravenous route adminstration

Usability Features

  • Prophylactic treatment must begin 24 hours before the operation and continue until 3-4 days after it
  • Therapy of hemorrhages must be prolonged for at least 24 hours after manifestations have disappeared
  • Particular care required in cardiopathic and hepatopathic subjects
  • Storage at 15-30°C in a dry place away from light and children's reach

Related Brands